Sunday, August 29, 2021

Exercise improves Alzheimer’s Disease via hormone irisin

Good news! Exercise more! This might be a long awaited breakthrough!

"New insight into the workings of the hormone irisin shows it has the ability to spur the cognitive benefits of exercise, holding promise for treating cognitive decline in Alzheimer's disease, Harvard Medical School scientists at Massachusetts General Hospital have found.

In a study published in Nature Metabolism, the research team report that irisin, secreted by muscles during exercise, could be an effective therapeutic for addressing deficits of the brain that result from Alzheimer’s disease. ...
For the first time, we showed that soluble irisin, and not its full-length parent protein FNDC5, is sufficient to confer the benefits of exercise on cognitive function,” ...
irisin, a small natural peptide, would be much easier to develop into a therapeutic than the much larger membrane-bound protein FNDC5
discovered irisin was able to cross the blood-brain barrier and directly affect the brain. ...
discovered irisin in 2012 ...
Researchers were further encouraged by the fact that irisin treatment was effective in Alzheimer’s disease mouse models even after the development of significant pathology. ...
Another important finding of the study is that irisin protects against neuroinflammation by acting directly on glial cells in the brain. ...
“Since irisin does not specifically target amyloid plaques, but rather neuroinflammation directly, we’re optimistic it could have beneficial effects on neurodegenerative diseases beyond just Alzheimer’s,” ..."

"Identifying secreted mediators that drive the cognitive benefits of exercise holds great promise for the treatment of cognitive decline in ageing or Alzheimer’s disease (AD). Here, we show that irisin, the cleaved and circulating form of the exercise-induced membrane protein FNDC5, is sufficient to confer the benefits of exercise on cognitive function. ...
Diminished pattern separation in F5KO mice can be rescued by delivering irisin directly into the dentate gyrus, suggesting that irisin is the active moiety. ...
Importantly, elevation of circulating irisin levels by peripheral delivery of irisin via adeno-associated viral overexpression in the liver results in enrichment of central irisin and is sufficient to improve both the cognitive deficit and neuropathology in AD mouse models. Irisin is a crucial regulator of the cognitive benefits of exercise and is a potential therapeutic agent for treating cognitive disorders including AD."

Exercise and Alzheimer’s Disease | Harvard Medical School Hormone found to confer benefits of exercise on cognitive function

No comments: